Trial Profile

A Single-arm, Open, Dose-increasing Phase I Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006 in Patients With her2-positive Advanced Solid Tumors

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 30 Dec 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BAT 1006 (Primary)
Indications Advanced breast cancer; HER2 positive breast cancer; Male breast cancer; Solid tumours
Focus Adverse reactions; First in man
Sponsors Bio-Thera Solutions

Most Recent Events

24 Dec 2024 Status changed from active, no longer recruiting to completed.
08 Oct 2023 Status changed from recruiting to active, no longer recruiting.
14 Aug 2023 Planned number of patients changed from 130 to 38.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com